We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Pfizer CEO Sees More Growth for Lipitor Despite Generic Rivals
Pfizer CEO Sees More Growth for Lipitor Despite Generic Rivals
January 13, 2006
Lipitor will continue to gain market share despite competition from cheaper rival cholesterol drugs that have gone off patent, Pfizer CEO Henry McKinnell said at a recent Morgan Stanley pharmaceutical conference in New York.